← Back to All US Stocks

Sintx Technologies, Inc. (SINT) Stock Fundamental Analysis & AI Rating 2026

SINT Nasdaq Surgical & Medical Instruments & Apparatus DE CIK: 0001269026
Recently Updated • Analysis: Apr 15, 2026 • SEC Data: 2025-12-31
STRONG SELL
92% Conf
Pending
Analysis scheduled

📊 SINT Key Takeaways

Revenue: $1.0M
Net Margin: -1,018.1%
Free Cash Flow: $-8.8M
Current Ratio: 1.51x
Debt/Equity: 0.00x
EPS: $-6.16
AI Rating: STRONG SELL with 92% confidence
Sintx Technologies, Inc. (SINT) receives a STRONG SELL rating with 92% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $1.0M, net profit margin of -1,018.1%, and return on equity (ROE) of -353.8%, Sintx Technologies, Inc. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete SINT stock analysis for 2026.

Is Sintx Technologies, Inc. (SINT) a Good Investment?

Claude

Sintx Technologies is in critical financial distress with unsustainable unit economics: $1.0M revenue generating $10.7M operating losses and $8.6M cash burn annually. At current burn rates, the $4.1M cash position provides only 5-6 months of runway, necessitating immediate dilutive capital raise, dramatic cost restructuring, or asset sale to avoid insolvency. Despite improving loss trends YoY, the absolute magnitude of cash consumption and severe revenue collapse (-64.7%) make this a distressed turnaround with significant execution risk.

Why Buy Sintx Technologies, Inc. Stock? SINT Key Strengths

Claude
  • + Debt-free capital structure with minimal long-term debt ($13K), reducing bankruptcy risk from leverage
  • + Positive gross margin (45.3%) indicates underlying product value despite revenue collapse
  • + Adequate short-term liquidity ratios (Current 1.51x, Quick 1.29x) provide near-term breathing room
  • + Net losses improving 39.3% YoY with EPS improving 59.4%, suggesting cost control efforts underway
  • + Insider activity (8 Form 4 filings in 90 days) indicates management remains engaged in potential turnaround

SINT Stock Risks: Sintx Technologies, Inc. Investment Risks

Claude
  • ! Catastrophic revenue decline of -64.7% YoY indicates collapsing core business demand
  • ! Operating cash burn of $8.6M annually with only $4.1M cash creates 5-6 month survival runway
  • ! Structural losses of -1053% operating margin and -1018% net margin are unsustainable without business model transformation
  • ! Extreme negative returns (ROE -353.8%, ROA -109%) destroying shareholder value at accelerated rate
  • ! Minimal revenue base ($1.0M) with massive fixed cost structure suggests weak unit economics
  • ! Company will require dilutive capital raise, asset sale, or acquisition within 6 months to avoid insolvency

Key Metrics to Watch

Claude
  • * Cash burn rate trend and cash reserves remaining to assess runway
  • * Quarterly revenue trends to determine if -64.7% decline stabilizes or continues
  • * Operating expenses and cost reduction initiatives to evaluate path to sustainable operations
  • * Capital raise announcements or financing activity indicating dilution risk
  • * Gross margin sustainability and product mix as company shrinks

Sintx Technologies, Inc. (SINT) Financial Metrics & Key Ratios

Revenue
$1.0M
Net Income
$-10.4M
EPS (Diluted)
$-6.16
Free Cash Flow
$-8.8M
Total Assets
$9.5M
Cash Position
$4.1M

💡 AI Analyst Insight

Sintx Technologies, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.

SINT Profit Margin, ROE & Profitability Analysis

Gross Margin 45.3%
Operating Margin -1,053.1%
Net Margin -1,018.1%
ROE -353.8%
ROA -109.0%
FCF Margin -860.1%

SINT vs Healthcare Sector: How Sintx Technologies, Inc. Compares

How Sintx Technologies, Inc. compares to Healthcare sector averages

Net Margin
SINT -1,018.1%
vs
Sector Avg 12.0%
SINT Sector
ROE
SINT -353.8%
vs
Sector Avg 15.0%
SINT Sector
Current Ratio
SINT 1.5x
vs
Sector Avg 2.0x
SINT Sector
Debt/Equity
SINT 0.0x
vs
Sector Avg 0.6x
SINT Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Sintx Technologies, Inc. Stock Overvalued? SINT Valuation Analysis 2026

Based on fundamental analysis, Sintx Technologies, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
-353.8%
Sector avg: 15%
Net Profit Margin
-1,018.1%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.00x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Sintx Technologies, Inc. Balance Sheet: SINT Debt, Cash & Liquidity

Current Ratio
1.51x
Quick Ratio
1.29x
Debt/Equity
0.00x
Debt/Assets
69.2%
Interest Coverage
-3.17x
Long-term Debt
$13.0K

SINT Revenue & Earnings Growth: 5-Year Financial Trend

SINT 5-year financial data: Year 2021: Revenue $606.0K, Net Income -$7.0M, EPS $-1.08. Year 2022: Revenue $1.6M, Net Income -$9.3M, EPS $-39.91. Year 2023: Revenue $2.6M, Net Income -$12.0M, EPS $-60.81. Year 2024: Revenue $2.9M, Net Income -$8.3M, EPS $-624.47. Year 2025: Revenue $2.9M, Net Income -$11.0M, EPS $-15.19.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Sintx Technologies, Inc.'s revenue has grown significantly by 376% over the 5-year period, indicating strong business expansion. The most recent EPS of $-15.19 indicates the company is currently unprofitable.

SINT Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-860.1%
Free cash flow / Revenue

SINT Quarterly Earnings & Performance

Quarterly financial performance data for Sintx Technologies, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $208.0K -$886.0K $-3.46
Q2 2025 $151.0K -$886.0K $-0.91
Q1 2025 $369.0K -$886.0K $-1.29
Q3 2024 $678.0K -$293.0K $-6.96
Q2 2024 $508.0K -$293.0K $-3.61
Q1 2024 $539.0K -$293.0K $-0.11
Q3 2023 $426.0K -$293.0K $-0.81
Q2 2023 $240.0K -$293.0K $-0.78

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Sintx Technologies, Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$8.6M
Cash generated from operations
Stock Buybacks
$133.0K
Shares repurchased (TTM)
Capital Expenditures
$185.0K
Investment in assets
Dividends
None
No dividend program

SINT SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Sintx Technologies, Inc. (CIK: 0001269026)

📋 Recent SEC Filings

Date Form Document Action
Apr 14, 2026 4 xslF345X06/ownership.xml View →
Mar 20, 2026 10-K form10-k.htm View →
Mar 18, 2026 4 xslF345X06/ownership.xml View →
Mar 10, 2026 4 xslF345X05/ownership.xml View →
Feb 25, 2026 4 xslF345X05/ownership.xml View →

Frequently Asked Questions about SINT

What is the AI rating for SINT?

Sintx Technologies, Inc. (SINT) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.

What are SINT's key strengths?

Claude: Debt-free capital structure with minimal long-term debt ($13K), reducing bankruptcy risk from leverage. Positive gross margin (45.3%) indicates underlying product value despite revenue collapse.

What are the risks of investing in SINT?

Claude: Catastrophic revenue decline of -64.7% YoY indicates collapsing core business demand. Operating cash burn of $8.6M annually with only $4.1M cash creates 5-6 month survival runway.

What is SINT's revenue and growth?

Sintx Technologies, Inc. reported revenue of $1.0M.

Does SINT pay dividends?

Sintx Technologies, Inc. does not currently pay dividends.

Where can I find SINT SEC filings?

Official SEC filings for Sintx Technologies, Inc. (CIK: 0001269026) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is SINT's EPS?

Sintx Technologies, Inc. has a diluted EPS of $-6.16.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is SINT a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Sintx Technologies, Inc. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is SINT stock overvalued or undervalued?

Valuation metrics for SINT: ROE of -353.8% (sector avg: 15%), net margin of -1,018.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy SINT stock in 2026?

Our dual AI analysis gives Sintx Technologies, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is SINT's free cash flow?

Sintx Technologies, Inc.'s operating cash flow is $-8.6M, with capital expenditures of $185.0K. FCF margin is -860.1%.

How does SINT compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -1,018.1% (avg: 12%), ROE -353.8% (avg: 15%), current ratio 1.51 (avg: 2).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 15, 2026 | Data as of: 2025-12-31 | Powered by Claude AI